Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.500
-0.051 (-9.34%)
At close: Jun 21, 2024, 4:00 PM
0.495
-0.005 (-1.02%)
After-hours: Jun 21, 2024, 7:11 PM EDT

Ensysce Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2017
Selling, General & Admin
5.366.9118.711.156.93
Upgrade
Research & Development
7.5919.844.694.393.4
Upgrade
Other Operating Expenses
-2.23-2.52-3.53-3.93-1.76
Upgrade
Operating Expenses
10.7224.2219.871.618.57
Upgrade
Operating Income
-10.72-24.22-19.87-1.61-8.57
Upgrade
Interest Expense / Income
0.350.111.310.96
Upgrade
Other Expense / Income
-0.46-0.167.92-2.670.58
Upgrade
Pretax Income
-10.61-24.17-29.080.06-10.1
Upgrade
Net Income
-10.61-24.17-29.080.06-10.1
Upgrade
Preferred Dividends
0.010.910.800
Upgrade
Net Income Common
-10.63-25.09-29.890.06-10.1
Upgrade
Shares Outstanding (Basic)
20000
Upgrade
Shares Outstanding (Diluted)
20000
Upgrade
Shares Change
1158.34%114.15%22.15%-33.68%314.69%
Upgrade
EPS (Basic)
-4.69-139.42-355.72--9.60
Upgrade
EPS (Diluted)
-4.69-139.42-355.72--9.60
Upgrade
Free Cash Flow
-10.78-17.88-8.24-1.25-0.94
Upgrade
Free Cash Flow Per Share
-4.76-99.39-98.10-18.98-9.02
Upgrade
EBITDA
-10.26-24.06-27.791.05-9.14
Upgrade
Depreciation & Amortization
00000
Upgrade
EBIT
-10.26-24.06-27.791.05-9.14
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).